Place of Origin: | CHINA |
---|---|
Brand Name: | TINGYI |
Certification: | GMP , ISO 9001:2008 |
Model Number: | CAS: 224785-91-5 |
Minimum Order Quantity: | 10g |
Price: | Contact Us |
Packaging Details: | Stealth And Discreet Packaging |
Delivery Time: | Within 7 Working Days |
Payment Terms: | Bank Transfer - Bitcoin - Western Union - MoneyGram |
Supply Ability: | 500 KG/Month |
Product Name: | Vardenafil | Relevant Product: | Vardenafil HCL |
---|---|---|---|
MF: | C23H33ClN6O4S | MW: | 525.06 |
Melting Point: | 214-216°C | Appearance: | White To Off-White Cyrstalline Solid |
High Light: | male enhancement steroids,sex steroid hormones |
Factory Direct Supply High Purity Sex Enhancer Vardenafil Powder & Vardenafil HCL
Description:
Vardenafil is a PDE5 inhibitor used for treating erectile dysfunction. Vardenafil's indications and
contra-indications are the same as with other PDE5 inhibitors. The difference between the
vardenafil molecule and is a nitrogen atom's position and the change of sildenafil's piperazine
ring methyl group to an ethyl group. Tadalafil is structurally different from both and vardenafil.
Vardenafil's relatively short effective time is comparable to but somewhat longer than sildenafil's.
Vardenafil is a centrally-acting phosphodiesterase 5 inhibitor that is clinically used to treat
erectile dysfunction. Vardenafil also exhibits antioxidative and antihypertensive activities and
shows some potential for synergistic chemotherapeutic ability through its modulation of cGMP-
NO signaling. This compound increases expression of NO and eNOS as well as activity of
superoxide dismutase, decreasing oxidative stress, pulmonary vascular resistance, and right
ventricular hypertrophy and increasing cardiac output in animal models of pulmonary arterial
hypertension. Vardenafil decreases proteinuria and glomerular damage in animal models of
diabetic nephropathy-induced cGMP pathway dysfunction. In cellular models, vardenafil
decreases secretion of IL-8 and expression of oxidative LDLR, suggesting potential benefit in the
treatment of benign prostatic hyperplasia/low urinary tract syndrome.
Application:
Beyond its indications for erectile dysfunction, vardenafil may be effective in the treatment of
premature ejaculation, where it may significantly increase the time from vaginal penetration to
ejaculation.
Vardenafil, as with all PDE5 inhibitors, should not be used by men taking nitrate medications,
because combining them with vardenafil might provoke potentially life-threatening hypotension
(low blood pressure).
Further, Vardenafil causing lengthening of the QT interval. Therefore it should not be taken by
men taking other medications that affect the QT interval (such as amiodarone).
Vardenafil is a PDE5 inhibitor used for treating erectile dysfunction. Vardenafil's indications and
contra-indications are the same as with other PDE5 inhibitors; it is closely related in function to
citrate and Tadalafil. The difference between the Vardenafil molecule and citrate is that a nitrogen
atom has different position and the change of piperazine ring methyl group to an ethyl group.
Tadalafil is structurally different from both and Vardenafil. Vardenafil's relatively short effective
time is comparable to but somewhat lon ger than .
Vardenafil, as with all PDE5 inhibitors, should not be used by men taking nitrate medications,
because combining them with Vardenafil might provoke potentially life-threatening hypotension .
Lab Test Result:
Test Items |
Specification |
Results |
Appearance |
White to off-White Crystalline Powder |
White Crystalline Powder |
Melting Point |
214-216°C |
214°C |
Related substances |
A single impurity≤1.0% |
0.11% |
Total impurities≤2.0% |
0.19% |
|
Loss on drying |
≤0.5% |
0.14% |
Assay |
97.0~103.0% |
99.3% |
Conclusion |
The specification conforms with Enterprise Standard |
Sex Drug Raw Powder
|
|
Sildenafil Citrate () |
Vardenafil |
Tadalafil (Cialis) |
Vardenafil HCL |
|
Yohimbine HCL |
HCL |
Avanafil |